10/21/2010 // US // Get Cancer Answers // News Desk
Los Angeles – A new study suggests colon cancer risks may be reduced by regularly taking low dose aspirin. As reported by HealthDay News, researchers found that the regimen may reduce risks of the disease by 24 percent.
Dr. Peter Rothwell, lead author of the study and a professor of neurology at John Radcliffe Hospital and the University of Oxford in the UK, is quoted in the report as stating of the findings, “This is proof that low-dose aspirin prevents colorectal cancer… Somewhat fortuitously, it mainly prevents those cancers that are least well-prevented by screening colonoscopy.”
Rothwell is further quoted as stating, “This additional cancer benefit of aspirin helps to tip the balance of risk and benefit in favor of healthy individuals who chose to take low-dose aspirin.”
More information about the study may be found in the Oct. 21 online publication of The Lancet.
The latest in Cancer News